SCHEMBL2857657

SCHEMBL2857657

COc1cc(-n2nc3c(c2N)c(=O)[nH]c2cc(OC(C)C(=O)O)ccc23)c(C)cc1Oc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.37
APOBEC3A P31941 1/20 0.37
CTDSP1 Q9GZU7 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
BTK Q06187 3/20 0.34
KYAT3 Q6YP21 1/20 0.33
AADAT Q8N5Z0 1/20 0.33
TTR P02766 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
KMT2A Q03164 1/20 0.32
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
TUBA1B P68363 1/20 0.32
TUBA4A P68366 1/20 0.32
TUBB4B P68371 1/20 0.32
TUBB3 Q13509 1/20 0.32
TUBB2A Q13885 1/20 0.32
TUBB8 Q3ZCM7 1/20 0.32
TUBA3E Q6PEY2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2866677 0.92 POLB (0.34) POLBAPOBEC3ACTDSP1APOBEC3GBTK
SCHEMBL5790922 0.88 GAA (0.37) POLBBTKKYAT3AADATKMT2A
SCHEMBL2861219 0.87 KYAT3 (0.36) POLBBTKKYAT3AADATKMT2A
SCHEMBL13025340 0.86 SMN1; SMN2 (0.40) POLBBTKKYAT3AADATKMT2A
SCHEMBL2868573 0.86 ADORA3 (0.39) BTKKYAT3AADATKMT2ANTRK1
SCHEMBL2869051 0.85 TSHR (0.34) BTKKYAT3AADATNTRK1IGF1R
SCHEMBL2861463 0.85 PDE2A (0.35) BTKKYAT3AADATNTRK1IGF1R
SCHEMBL2867315 0.84 PDGFRB (0.33) BTKKYAT3AADATNTRK1IGF1R
SCHEMBL2857869 0.82 SMN1; SMN2 (0.35) POLBBTKNTRK1IGF1RFGFR1
SCHEMBL2865482 0.79 KDM4E (0.34) BTKKMT2AALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7842701-B2 Pyrazoloquinolone derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-11-30 US disclosed
US-20070281963-A1 Pyrazoloquinolone Derivative And Use Thereof TAKEDA PHARMACEUTICAL COMPANY (JP) 2007-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281963-A1 Pyrazoloquinolone Derivative And Use Thereof MAP3K20, MAP4K5, MAP4K3 POLB 4153/4885APOBEC3A 4781/4885CTDSP1 3313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.